Proactive - Interviews for investors

Proactive - Interviews for investors

Download on the App Store

Proactive - Interviews for investors episodes

  • Futura Medical achieves milestone with first profit as it eyes US Eroxon launch
    ​​​​​​​Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder joined Proactive's Stephen Gunnion with details of company’s latest financial results and future outlook. Barder highlighted that Futura Medical has increased guidance on both profit and revenue for the remainder of the year. Its flagship product, Eroxon, a clinically proven treatment for erectile dysfunction, has now launched in ten countries, with its most recent debut in Mexico.
    Barder emphasised the significance of Eroxon entering the US market as the first over-the-counter (OTC) treatment for erectile dysfunction, where competitors like Viagra and Cialis still require a prescription. He also mentioned the company’s strategy for sustainable growth and the development of a strong product pipeline, which includes future launches in other regions.
    He concluded by sharing Futura Medical’s milestone achievement of generating its first profit, with revenue increasing by over 300% to £7 million. With a robust R&D team and expansion efforts underway, Barder expressed optimism about continued growth and building a viable consumer healthcare company.
    Watch the full interview to learn more about Futura Medical’s growth plans. Don’t forget to like this video, subscribe to Proactive’s channel, and enable notifications for future updates.
    #FuturaMedical #Eroxon #JamesBarder #EDTreatment #HealthcareInnovation #GlobalLaunch #ConsumerHealthcare #OTCTreatment #ProactiveInterview #HealthcareMarket #ErectileDysfunction #USMarketExpansion #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    9 min
  • Finseta CEO discusses 40% H1 revenue growth following strategic shift
    Finseta plc (AIM:FIN) CEO James Hickman takes Proactive's Stephen Gunnion through the company’s strong financial performance for H1 2024, marking a 40% revenue increase after exiting its white-label business. Hickman emphasised that Finseta’s direct-to-market strategy boosted margins to 65.7%, highlighting its scalability and cost-efficiency. He also discussed the significant 29% rise in average transaction value, which came from the company's strategic focus on deepening customer relationships through exceptional service.
    Additionally, Hickman provided updates on Finseta’s regulatory approval in Canada and the upcoming Mastercard product launch, expected by the end of September 2024. Finseta has also expanded its currency capabilities from 58 to over 140, positioning the company for further geographic and product expansion.
    “We're confident with our expectations for the full year,” Hickman stated, noting that the momentum from the first half has continued into H2.
    For more videos, be sure to visit Proactive's YouTube channel. Don't forget to give this video a like, subscribe to the channel, and enable notifications for future updates.
    #Finseta #FintechGrowth #RevenueIncrease #H12024Results #JamesHickman #PaymentSolutions #MastercardLaunch #GeographicExpansion #BusinessStrategy #ProactiveInvestors
    #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    6 min
  • Blackbird ends first half well positioned to grow elevate.io with strengthened board board
    Blackbird PLC (AIM:BIRD, OTC:BBRDF) CEO Ian McDonough, chair Anne de Kerckhove and non-executive director Youri Hazanov joined Proactive's Stephen Gunnion to discuss the strong progress that the company has made with its flagship elevate.io platform and new and recent board appointments.
    Unveiling the company's interim results, McDonough highlighted the company's involvement in high-profile events like the Paris Summer Games while acknowledging a 30% drop in top-line growth due to non-renewed deals. However, he shared exciting news about renewed partnerships, including Univision and CBS, and a strong second half.
    In particular, the conversation focused on elevate.io, a tool designed to streamline video editing and collaboration for content creators. McDonough shared that the platform has grown from 800 to 1,800 verified users in just five days following a campaign using Google AdWords. He attributed this growth to the product's key features and its appeal to creators.
    De Kerckhove also shared her motivation for joining Blackbird, citing her experience in the gaming and ad-tech industries. She highlighted the importance of providing content creators with efficient tools, allowing them to focus on creating rather than technical barriers. Hazanov emphasised Elevate’s potential to transform the creator economy, drawing on his experience from YouTube and Jellysmack.
    Don't miss the full video to hear more insights from Blackbird PLC’s leadership. And make sure to give the video a like, subscribe to the Proactive channel, and enable notifications for future content.
    #BlackbirdPLC #ElevatePlatform #ContentCreationTools #VideoEditing #SaaS #CreatorEconomy #IanMcDonough #AnneDeKerckhove #YouriHazanov #InvestorUpdates #BusinessGrowth
    #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    13 min
  • John Shaw discusses Itaconix’s half-year results & digital strategy
    Itaconix CEO John Shaw joined Steve Darling from Proactive to provide an update on the company’s recent performance and initiatives, with a particular focus on its evolving digital marketing strategy.
    Shaw expressed optimism about Itaconix’s trajectory, reflecting on both the successes and challenges faced in the first half of 2024. He noted that while the company’s restructuring efforts resulted in lower revenues, they successfully improved gross profit margins, which are now nearing their target of over 35%.
    Shaw emphasized that Itaconix is prioritizing profitability by leveraging its unique, high-value ingredients used in everyday consumer products such as detergents and deodorants.
    He also unveiled a new corporate website aimed at attracting brand managers by offering specific value propositions, which will facilitate faster and more efficient product launches. Shaw explained, “Our digital marketing initiative allows us to target very specific audiences with tailored value propositions, speeding up engagement and adoption.”
    As Itaconix enters the second half of 2024, digital marketing will remain a key component in driving growth, expanding the company’s reach, and capitalizing on new market opportunities.
    #proactiveinvestors #itaconixplc #aim #itx #otcqb #itxxf #DigitalMarketing #ConsumerProducts #Sustainability #Profitability #GrossMargin #BrandManagers #InnovativeIngredients #ProactiveInvestors #CorporateStrategy#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    5 min
  • hVIVO CEO discusses record H1 revenue and strategic expansion
    hVIVO PLC (AIM:HVO) chief executive Yamin (Mo) Khan speaks with Proactive's Stephen Gunnion about the company's achievements in the first half of 2024, including a 31% increase in revenue, reaching £35.6 million. Khan highlighted the company's record EBITDA of £8.7 million, reflecting a 68% year-on-year growth. He attributed these successes to the opening of the world’s largest human challenge trial facility in Canary Wharf, which includes 50 beds for CL3 level pathogen trials.
    Khan also spoke about hVIVO’s strategic expansion of service offerings beyond human challenge trials, including laboratory services and patient recruitment via its FluCamp platform. He emphasised the company’s strong order book, valued at £71 million, and its sales pipeline, which includes £40 million worth of opportunities.
    As hVIVO looks ahead, Khan reiterated the company’s guidance for 2024 revenue of £62 million and an EBITDA margin at the upper end of market expectations. With an optimistic outlook for future growth, hVIVO remains on track to achieve its 2028 target of £100 million.
    Watch the full interview to learn more about hVIVO’s financial performance, new contracts, and the CEO’s insights into the company's expansion plans.
    Make sure to visit Proactive's YouTube channel for more insightful interviews, and don't forget to like, subscribe, and hit the notification bell for future content!
    #hVIVO #HumanChallengeTrials #ClinicalResearch #BiotechGrowth #MoKhan #ClinicalTrials #CanaryWharf #LabServices #FluCamp #RevenueGrowth #HealthcareInnovation #ProactiveInvestors #EBITDA #2024Targets #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    8 min
  • Tissue Regenix reports strong first half as it focuses on four growth pillars
    Tissue Regenix Group PLC (AIM:TRX) CEO Danny Lee and CFO David Cocke take Proactive's Stephen Gunnion through company’s significant financial progress and strategic growth pillars. Cocke highlighted a strong first half of 2024, with revenues increasing by 16% to $16.4 million. This marks the eighth consecutive growth period, with the gross profit margin rising to 53%, and EBITDA more than doubling to $1.1 million. Notably, the company achieved its first pre-tax profit, a milestone in its history.
    Discussing the growth drivers, Cocke emphasised the 26% growth in mineralised bone matrix products and the addition of 24 new distributors. The company’s tissue partnerships and regulatory evolution, such as its move to develop medical devices, were key components of the strategy.
    Lee elaborated on the company’s 4S and the four growth pillars: base business, tissue partnerships, regulatory evolution, and market expansion. Tissue Regenix has been expanding into global markets and developing innovative products like OrthoPure XT for knee surgeries in collaboration with Geistlich Pharma in Switzerland. He noted that despite regulatory delays in certain regions, the company remains committed to global growth and scaling its operations.
    For more insights from the interview, make sure to watch the full video!
    Don’t forget to like the video, subscribe to Proactive’s YouTube channel, and turn on notifications for future updates.
    #TissueRegenix #MedicalDevices #Orthopedics #RevenueGrowth #BiotechInvesting #HealthcareInnovation #ProactiveInvestors #CEOInterview #EBITDA #SurgicalTechnology
    #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    9 min
  • Electric Guitar CEO discusses strong progress since May listing; new contract with Jewson
    Electric Guitar PLC (AIM:ELEG) CEO John Regan discusses the company's development over the last four months since its market launch in May. During the interview, Regan detailed the recent restructuring efforts, including the addition of sales and marketing personnel and product optimisation, which has significantly reduced deployment times for their solutions.
    Regan touched on a new agreement with Jewson, one of the UK's prominent suppliers of sustainable building materials. The collaboration will see the launch of a sustainability-focused microsite that integrates 3radical’s Voco platform, aiming to enhance customer engagement both online and offline.
    Additionally, Regan announced the launch of the Voco Solutions Portal (VSP), a self-serve platform that will allow clients to deploy Electric Guitar technology in as little as 1 to 2 hours.
    “We’ve gone from six months to 1 or 2 hours, which is really significant because it means clients can test our technology in different ways and use it immediately,” Regan explained. The VSP will be showcased at the upcoming DMEXCO conference in Cologne, with live demos planned.
    Regan also discussed strategic partnerships with companies like Sophus3 and Digital Alchemy, which have expanded Electric Guitar’s market presence and customer base across different verticals.
    For more insightful updates from Electric Guitar PLC and other industry leaders, visit Proactive's
    YouTube channel. Don’t forget to give this video a like, subscribe, and turn on notifications for future content!
    #ElectricGuitarPLC #JohnRegan #VocoSolutionsPortal #DMEXCO2024 #MarketingTechnology #AIinMarketing #DigitalTransformation #TechInnovation #CustomerEngagement #BusinessGrowth
    This completes Phase 1. Let me know when you're ready to move on to Phase 2, where I'll create the full transcription, interview summary, and an investor-focused article.#proactiveinvestors
    #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    8 min
  • North Bay Resources begins gold shipments from Fran gold project and acquires interest in Taber mine
    North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to announce that the company has initiated gold ore shipments from its Fran Gold Project to the Bishop Gold Mill.
    A four-man crew has been deployed to the site, with the first tractor trailers set to arrive next week. The initial shipment will consist of 44 tons of surface material, manually loaded into one metric tonne super-sacks for transport on flat-bed tractor trailers.
    Lazerson shared that the target material has been recently assayed, with gold grades ranging between 1.2 to 2.3 ounces per tonne. Following successful optimization and processing, the company plans to increase shipments throughout the fall season.
    Additionally, North Bay Resources has entered into an agreement to acquire a 50% interest in the Taber Mine in Sierra County, California. The acquisition terms include extracting 5,000 tons of material or investing $1.5 million within 30 months. The Taber Mine, located on the same channel as the highly productive Union-Keystone Mine, represents a largely untapped deposit, offering significant growth potential.
    #proactiveinvestors #northbayresourcesinc #otc #nbri #PlatinumConcentrate #NorthBayResources #MiningNews #CaliforniaGold #JaredLazerson #GoldRush #ProactiveInvestors #PreciousMetals #MiningUpdates ---#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    6 min
  • Nanoviricides investigates NV-387 for MPOX treatment amid global outbreak
    Nanoviricides CEO Dr Anil Diwan joined Steve Darling from Proactive to discuss the company's exploration of using its antiviral candidate, NV-387, for the treatment of MPOX patients under the World Health Organization's (WHO) MEURI protocol. This comes in response to the 2024 MPOX outbreak, which is rapidly spreading across more than ten African countries, with additional cases reported in Thailand and Sweden.
    Dr. Diwan explained that NV-387 has already completed Phase I clinical trials for safety and tolerability, with no adverse events reported, indicating excellent safety.
    The compound has shown strong survival improvement in animal models, performing on par with the currently approved drug tecovirimat, demonstrating significant potential for effectiveness.
    As MPOX Clade 1/1b strains demand the development of new therapeutics due to limitations in existing treatments, NV-387 could play a critical role.
    In an animal model study simulating direct skin infection, the primary mode of MPOX transmission, NV-387 was as effective as tecovirimat, highlighting its promise as a novel broad-spectrum antiviral treatment.
    #proactiveinvestors #nanoviricidesinc #nyseamerican #nnvc #NV387 #VirusTreatment #Antiviral #mPox #Biotechnology #RSV #Influenza #ClinicalTrials #HealthcareInnovation #ProactiveInvestors #PharmaceuticalResearch#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    6 min
  • Alvopetro Energy CEO discusses breakthrough natural gas operations in Brazil and future growth plans
    Alvopetro Energy CEO Corey Ruttan joined Steve Darling from Proactive to discuss the company’s impressive achievements and future outlook in Brazil's natural gas sector.
    Ruttan highlighted the pivotal moment on July 5, 2020, when Alvopetro became the first independent company to deliver sales-specified natural gas to the local market, breaking the long-standing monopoly held by the state oil company, Petrobras.
    Operating in the Reconcavo Basin in northeast Brazil, Alvopetro supplies natural gas to Bahia Gas, with its production site strategically located just 15 km from key industrial consumers.
    Ruttan also shared updates on the company's ongoing operations, including the exciting progress at the Murucututu asset, where two recompletions are currently underway.
    Looking toward the future, Alvopetro has set its sights on expanding production through the drilling of five new development wells at the Caburé unit, with targeted growth anticipated in late 2024 and into 2025. Ruttan emphasized Alvopetro’s ability to swiftly convert new gas discoveries into production and cash flow, thanks to the company’s established infrastructure.
    In addition to discussing operational achievements, Ruttan outlined the company’s multi-year development strategy, which will drive continued growth and activity over the next six months. He also highlighted the strong relationships Alvopetro has built with local communities, regulators, and government officials, further solidifying the company’s position in Brazil’s evolving energy landscape.
    #proactiveinvestors #alvopetroenergyltd #tsxv #alv #otcqx #alvof #CoreyRuttan #NaturalGas #BrazilEnergy #OilAndGas #EnergySector #Murucututu #GasProduction #BahiaGas #BrazilianMarket #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    6 min

About Proactive - Interviews for investors

From the publisher's feed

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage.

More shows like Proactive - Interviews for investors

Autoline Daily by Autoline

Autoline Daily

80 Listeners

ev.news by Martyn Lee

ev.news

470 Listeners